HealthcareBiotechnology
Overview
Analysts
About The Company
Alligator Bioscience is developing antibody-based drugs for the treatment of cancer. The company specializes in the development of tumor-targeted immunotherapies, in particular agonist mono- and bispecific antibodies, and is active in the early stages of drug development, from concept to phase II clinical trials. Alligator was founded in 2001 and is located at Medicon Village in Lund, Sweden.
Alligator
Insider Trades for Alligator Bioscience
No insider trades for the selected period.
